BioSpace News Archive

Aura Biosciences Inc. today announced that the European Commission has granted Orphan Drug Designation to AU-011, its first VDC product candidate, for the treatment of uveal melanoma.

Spok Holdings, Inc. (NASDAQ: SPOK) (“Spok” or the “Company”), a global leader in healthcare communications, today announced that it has reduced the size of its Board of Directors (the “Board”) to six members to better align the Board’s size and composition with the Company’s recently announced business strategy.

We are excited to have Romesh join Ceptur as we advance our broad discovery pipeline based on our proprietary U1 Adaptor technology.

Marinus Pharmaceuticals, Inc. today reported business highlights and financial results for the fourth quarter and year ended December 31, 2021.

Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced that Andy Astor, Chief Executive Officer of Nephros, will be presenting at the 2022 Virtual Growth Conference.

Jiangsu Recbio Technology Co., Ltd. announced the proposed listing of its H Shares on the Main Board of The Stock Exchange of Hong Kong Limited.

Bavarian Nordic A/S announced, that it has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-based specialty pharmaceutical company, on the development and commercialization of MVA-BN® RSV against respiratory syncytial virus in adults in Chinese Mainland, Hong Kong, Macau, Taiwan, South Korea and certain Southeast Asian countries.

Mainz Biomed N.V. announces that Guido Baechler, Chief Executive Officer, will ring the closing bell at Nasdaq MarketSite in New York’s Times Square , Monday, March 21st, 2022 at 4:00 pm ET.

Ultimovacs ASA announced that it will host a key opinion leader webinar on the unmet need and treatment landscape of melanoma on Monday, March 28, 2022 at 10:00amET/4:00amCET.

Osler Diagnostics is pleased to announce the appointment of Chris Smith as Chairman of the Board of Directors and David Berry as a Non-Executive Director, with immediate effect.